Polar application of test substances in an organotypic environment and under continuous medium flow: A new tissue-based test concept for a broad range of applications in pharmacotoxicology

Toxicology in Vitro

Volumn 14, Issue 3, 2000, Pages 265-274

  Kloth, S ^a   Kobuch, K ^b   Domokos, J ^a   Wanke, C ^a   Monzer, J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Biocompatibility; In vitro test model; Serum free perfusion culture; Toxicology

Indexed keywords

PERFLUORODECALIN; PERFLUOROPHENANTHRENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL; BLOOD VESSEL INJURY; EYE TOXICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PERFUSION; RABBIT; RETINA BLOOD VESSEL; TECHNIQUE; TISSUE; TISSUE CULTURE; TOXICITY TESTING; VITREOUS BODY;

ANIMALS; CULTURE MEDIA; KIDNEY; PERFUSION; RABBITS; TISSUE PRESERVATION; TOXICOLOGY; VITREOUS BODY;

ORYCTOLAGUS CUNICULUS;

EID: 0034012658     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(00)00010-2     Document Type: Article

References (29)

1. Babich H., Borenfreund E. Cytotoxicity and genotoxicity assays with cultured fish cells: a review. Toxicology in Vitro. 5:1991;91-100.
2. Bach P.H., Vickers A.E.M., Fisher R., Baumann A., Brittebo E., Carlile D.J., Koster H.J., Lake B.G., Salmon F., Sawyer T.W., Skibinski G. The use of tissue slices for pharmacotoxicology studies. The report and recommendations of ECVAM workshop 20. ATLA. 24:1996;893-923.
3. Barile F. A. (1997) Continuous cell lines as a model for drug toxicity assessment. In In vitro Methods in Pharmaceutical Research, ed. J. V. Castell and M. J. Gomez-Lechon, pp. 33-54. Academic Press, London.
4. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 125:1998;1591-1598.
5. Chirila T.V., Tahija S., Hong Y., Vijayasekaran S., Constable I.J. Synthetic polymers as materials for artificial vitreous body: review and recent advances. Journal of Biomaterial Applications. 9:1994;37-121.
6. Clemedson C., Andersson M., Aoki Y., Barile F.A., Bassi A.M., Calleja M.C., Castano A., Clothier R.H., Dierieckx P., Ekwall B., Ferro M., Fiskejo G., Garza-Ocanas L., Gomez-Lechon M.J., Gulden M., Hall T., Imai K., Isomaa B., Kahru A., Kerszman G., Kjellstrand P., Kristen U., Kunimoto M., Karenlampi S., Lewan L. MEIC evaluation of acute systemic toxicity: Part IV. In vitro results from 67 toxicity assays used to test reference chemicals 31-50 and a comparative cytotoxicity analysis. ATLA. 26:1998;131-183.
7. Ekwall B. Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. II Drug toxicity in the MIT-24 system compared with mouse and human lethal dosage of 52 drugs. Toxicology Letters. 5:1980;309-317.
8. Ekwall B. Correlation between cytotoxicity in vitro and LD50 values. Acta Pharmacologica et Toxicologica. 52:(Suppl. 2):1983;80-99.
9. Hawksworth G.M., Bach P.H., Nagelkerke J.F., Dekant W., Diezi J.E., Harpur E., Lock E.A., MacDonald C., Morin J-P., Pfaller W., Rutten A. A. J. J.L., Ryan M.P., Toutain H.J., Trevisan A. Nephrotoxicity testing in vitro. ATLA. 23:1995;713-727.
10. Kloth S., Ebenbeck C., Kubitza M., Schmidbauer A., Röckl W., Minuth W.W. Stimulation of renal microvascular development under organotypic culture conditions. FASEB Journal. 9:1995;963-967.
11. Kloth S., Ebenbeck C., Monzer J., de Vries U., Minuth W.W. Three dimensional organization of the developing vasculature of the kidney. Cell and Tissue Research. 287:1997;193-201.
12. Kloth S., Eckert E., Klein S.J., Monzer J., Wanke C., Minuth W.W. Long-term preservation of the gastric epithelium under organotypic perfusion culture (Letter to the Editor). In vitro Cellular Developmental Biology. A34:1998;515-517.
13. Kloth S., Schmidbauer A., Kubitza M., Weich H., Minuth W.W. Developing renal microvasculature can be maintained under perfusion culture conditions. European Journal of Cell Biology. 63:1994;84-95.
14. Klug S., Merker H-J., Jäckh R. Potency of monomethyl-dimethylformamide and some of their metabolites to induce abnormal development in a limb bud organ culture. Toxicology in Vitro. 12:1998;123-132.
15. Kobuch K., El-Batarny A., Schröder J., Ueda N. and Gabel V. P. 1997. Perfuorophenantrene as a vitreous substitute causes vascular and neural damage in the rabbit eye - a light and electronmicroscopical study. Investigative Ophthalmology and Visual Science. 38. 664. (Association for Research in Vision and Ophthalmology Meeting (ARVO), Abstract No. 3111).
16. Kuwabara T., Cogan D.G. Studies of retinal vascular patterns. Archives of Ophthalmology. 64:1960;124/904-131/911.
17. Meinert H., Mader J., Rohlke W., Geister U., Lang G.E., Lang G.K., Kreiner C.F. Chemical and physical stability of perfluorocarbons with laser treatment. European Journal of Ophthalmology. 5:1995;24-219.
18. Minuth W.W. Neonatal rabbit kidney cortex in culture as a tool for the study of collecting duct formation and nephron differentiation. Differentiation. 36:1987;12-22.
19. Minuth W.W., Dermietzel R., Kloth S., Hennerkes B. A new method culturing renal cells under permanent perfusion ad producing a luminal-basal medium gradient. Kidney International. 41:1992;215-219.
20. Minuth W.W., Sittinger M., Kloth S. Tissue engineering - generation of differentiatiated artificial tissues for biomedical applications. Cell and Tissue Research. 291:1998;1-11.
21. Mitchell de I. G. and Combes R. D. (1997) In vitro genotoxicity and cell transformation assessment. In In vitro Methods in Pharmaceutical Research, ed. J. V. Castell and M. J. Gomez-Lechon, pp. 317-352. Academic Press, London.
22. Nabih M., Peyman G.A., Clarc L.C., Hoffman R.E., Miceli M., Abou Steit M., Tawakol M., Liu K.R. Experimental evaluation of Perfluorophenantrene as a high specific gravity vitreous substitute: A preliminary report. Ophthalmic Surgery. 20:1989;286-298.
23. Pierce E.A., Foley E.D., Smith L.E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Archives of Ophthalmology. 114:1996;28-1219.
24. Purves D., Harvey C., Tweats D., Lumley C.E. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry. Mutagenesis. 10:1995;297-312.
25. Schmalix W.A., Lang D., Schneider A., Bocker R., Greim H., Doehmer J. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines. Drug Metabolism and Disposition. 24:1996;1314-1319.
26. Sittinger M., Bujia J., Minuth W.W., Hammer C., Burmester G.R. Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture. Biomaterials. 15:1994;451-456.
27. Spielmann H., Liebsch M., Kalweit S., Moldenhauer F., Wirnsberger T., Holzhütter H.-G., Schneider B., Glaser S., Gerner I., Pape W.J.W., Kreiling R., Krauser K., Miltenburger H.G., Steiling W., Luepke N.P., Müller N., Kreuzer H., Mürmann P., Spengler J., Bertram-Neis E., Siegemund B., Wiebel F.J. Results of a validation study in Germany in two in vitro alternativees to the Draize eye irritation test the HET-CAM test and the 3T3 NRU cytotoxicity test. ATLA. 24:1996;741-859.
28. Velikay M., Wedrich A., Stolba U., Datlinger P., Li Y., Binder S. Experimental long term vitreous replacement with purified and non purified perfluorodecalin. American Journal of Ophthalmology. 116:1993;565-570.
29. Wiebel F.J., Andersson T.B., Casciano D.A., Dickins M., Fischer V., Glatt H., Horbach J., Langenbach R.J., Luyten W., Turchi G., Vandewalle A. Genetically engineered cell lines: Characterization and applications in toxicity testing. The report and recommendations of ECVAM workshop report 26. ATLA. 25:1997;625-639.